Shortly after Yoel Romero’s fight with Ronaldo “Jacare” Souza at UFC 194, news spread of Romero’s “potential Anti-Doping Policy violation” that stemmed from an out-of-competition sample collection.
Romero and his legal team have claimed that a dietary supplement is the cause of Romero’s “potential violation.” Romero and his team claim that the supplement unknowingly was tainted with banned substances and recently announced that they would be filing an arbitration case for USADA’s nine-month suspension that they initially had been discussing in result of the violation.
A report from MMA Fighting claims that Romero and his team have settled on an agreement for a shorter suspension than the initial nine-month term that was being discussed.
The official announcement from USADA is expected to be released soon. Stay tuned to BJPENN.COM for updates as they become available.
UPDATE from USADA release:
This article appeared first on BJPENN.COM
April 4, 2016
USADA announced today that UFC athlete, Yoel Romero, of Miami, Fla., has accepted a 6-month sanction for an anti-doping policy violation after testing positive for a prohibited substance from a contaminated supplement.
Romero, 38, tested positive for Ibutamoren following an out-of-competition test conducted on December 16, 2015 in Miami, Florida. Ibutamoren is a Growth Hormone Secretagogue and a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List.
Following notification of his positive test, Romero provided USADA with access to the dietary supplement products he was using at the time of the relevant sample collection. Although Ibutamoren was not listed on any of the supplement labels, preliminary testing conducted on one of the products indicated that it contained the prohibited substance. The presence of an undisclosed prohibited substance in a product is regarded as contamination.
At USADA’s request, the WADA-accredited laboratory in Salt Lake City, Utah, independently obtained and analyzed the contents of an unopened container of the supplement in question. That testing conclusively confirmed that a supplement Romero used was contaminated with Ibutamoren. The product has since been added to the list of high risk supplements maintained on USADA’s online dietary supplement safety education and awareness resource – Supplement 411 (www.supplement411.org).
Under the UFC Anti-Doping Policy, as well as the World Anti-Doping Code, the determination that an athlete’s positive test was caused by a contaminated product may result in a reduced sanction. The sanction for a doping offense resulting from the use of a contaminated product ranges from a reprimand and no period of ineligibility, at a minimum, to a two-year period of ineligibility, at a maximum.
Romero’s period of ineligibility began on January 12, 2016, the date on which he was provisionally suspended from competition. Because USADA was able to confirm, based on a negative fight night test result, that Romero’s use of the contaminated supplement began after he competed at UFC 194 on December 12, 2015, his competitive results from that event were not disqualified.
”This case clearly demonstrates some of the dangers inherent to supplement use,” said USADA’s Special Advisor on Drugs and Supplements, Dr. Amy Eichner. “When considering whether to incorporate supplements into a training plan, it is vitally important that athletes exercise the upmost care in order to avoid making a decision that could endanger their eligibility, reputation or general health and wellness.”
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (www.ufc.usada.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.ufc.globaldro.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts.